Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG CLASS:
RAS inhibitor
DRUG CLASS:
RAS inhibitor
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Related drugs:
‹
RMC-6236 (3)
JZP815 (2)
RMC-7977 (2)
IODVA1 (1)
NEO100 (1)
DO-2 (0)
GI-4000 (0)
antroquinonol (0)
KY1022 (0)
PRLX 93936 (0)
RMC-6236 (3)
JZP815 (2)
RMC-7977 (2)
IODVA1 (1)
NEO100 (1)
DO-2 (0)
GI-4000 (0)
antroquinonol (0)
KY1022 (0)
PRLX 93936 (0)
›
Associations
(9)
News
Trials
VERI cancer hierarchy
Reset Filters
IDH1 mutation
Glioblastoma
IDH1 mutation
Glioblastoma
NEO100
Sensitive: C2 – Inclusion Criteria
NEO100
Sensitive
:
C2
NEO100
Sensitive: C2 – Inclusion Criteria
NEO100
Sensitive
:
C2
KRAS G12
Non Small Cell Lung Cancer
KRAS G12
Non Small Cell Lung Cancer
RMC-6236
Sensitive: C2 – Inclusion Criteria
RMC-6236
Sensitive
:
C2
RMC-6236
Sensitive: C2 – Inclusion Criteria
RMC-6236
Sensitive
:
C2
KRAS G12
Pancreatic Ductal Adenocarcinoma
KRAS G12
Pancreatic Ductal Adenocarcinoma
RMC-6236
Sensitive: C3 – Early Trials
RMC-6236
Sensitive
:
C3
RMC-6236
Sensitive: C3 – Early Trials
RMC-6236
Sensitive
:
C3
BCR-ABL1 T315I
B Acute Lymphoblastic Leukemia
BCR-ABL1 T315I
B Acute Lymphoblastic Leukemia
IODVA1
Sensitive: D – Preclinical
IODVA1
Sensitive
:
D
IODVA1
Sensitive: D – Preclinical
IODVA1
Sensitive
:
D
KRAS mutation
Pancreatic Ductal Adenocarcinoma
KRAS mutation
Pancreatic Ductal Adenocarcinoma
RMC-6236
Sensitive: D – Preclinical
RMC-6236
Sensitive
:
D
RMC-6236
Sensitive: D – Preclinical
RMC-6236
Sensitive
:
D
KRAS mutation
Non Small Cell Lung Cancer
KRAS mutation
Non Small Cell Lung Cancer
JZP815
Sensitive: D – Preclinical
JZP815
Sensitive
:
D
JZP815
Sensitive: D – Preclinical
JZP815
Sensitive
:
D
KRAS mutation
Colorectal Cancer
KRAS mutation
Colorectal Cancer
JZP815
Sensitive: D – Preclinical
JZP815
Sensitive
:
D
JZP815
Sensitive: D – Preclinical
JZP815
Sensitive
:
D
FLT3 mutation
Acute Myelogenous Leukemia
FLT3 mutation
Acute Myelogenous Leukemia
gilteritinib + RMC-7977
Sensitive: D – Preclinical
gilteritinib + RMC-7977
Sensitive
:
D
gilteritinib + RMC-7977
Sensitive: D – Preclinical
gilteritinib + RMC-7977
Sensitive
:
D
FLT3 mutation + NRAS mutation
Acute Myelogenous Leukemia
FLT3 mutation + NRAS mutation
Acute Myelogenous Leukemia
gilteritinib + RMC-7977
Sensitive: D – Preclinical
gilteritinib + RMC-7977
Sensitive
:
D
gilteritinib + RMC-7977
Sensitive: D – Preclinical
gilteritinib + RMC-7977
Sensitive
:
D
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login